Generali Investments Towarzystwo Funduszy Inwestycyjnych Exact Sciences Corp Transaction History
Generali Investments Towarzystwo Funduszy Inwestycyjnych
- $172 Billion
- Q4 2024
A detailed history of Generali Investments Towarzystwo Funduszy Inwestycyjnych transactions in Exact Sciences Corp stock. As of the latest transaction made, Generali Investments Towarzystwo Funduszy Inwestycyjnych holds 24,000 shares of EXAS stock, worth $1.13 Million. This represents 0.78% of its overall portfolio holdings.
Number of Shares
24,000
Previous 18,000
33.33%
Holding current value
$1.13 Million
Previous $1.23 Billion
9.98%
% of portfolio
0.78%
Previous 0.78%
Shares
4 transactions
Others Institutions Holding EXAS
# of Institutions
672Shares Held
164MCall Options Held
4.25MPut Options Held
1.89M-
Capital World Investors Los Angeles, CA17.5MShares$825 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA17MShares$801 Million0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$568 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.1MShares$567 Million0.13% of portfolio
-
State Street Corp Boston, MA6.23MShares$293 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $8.33B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...